Of the four well defined subtypes of breast cancer (human epidermal growth factor receptor 2 over-expressing (HER2+), triple-negative breast cancer (TNBC), luminal A, and luminal B), cancers diagnosed among young women are more likely to be TNBC or HER2+ [2, 14, 15]. This evidence concerns the gene ERBB2 and cancer.